Futuximab
Product Specifications
CAS Number
1310460-85-5
Target
EGFR
Related Pathways
JAK/STAT signaling, Angiogenesis, Tyrosine Kinase/Adaptors
Purity
0.975
Bioactivity
Futuximab is a chimeric monoclonal antibody targeting EGFR, commonly used in combination with zatuximab to form Sym004. Sym004 targets non-overlapping epitopes on EGFR, exhibiting antitumour activity.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
FRE2222 1 Each
Bravo Freezer Boxes Divider - 13 x 13 Array for 8mm Diameter Tubes
Sign In for Pricing
View Details 
MBS1021976-01 0.02 mg (E-Coli)
Recombinant Pseudomonas putida Ribonuclease P protein component (rnpA)
Sign In for Pricing
View Details MBS1021976-02 0.1 mg (E-Coli)
Recombinant Pseudomonas putida Ribonuclease P protein component (rnpA)
Sign In for Pricing
View Details MBS1021976-03 0.02 mg (Yeast)
Recombinant Pseudomonas putida Ribonuclease P protein component (rnpA)
Sign In for Pricing
View Details